Why third-party purity testing matters for peptides

What “third-party tested” actually means

A purity figure printed on a vial label is a claim. A purity figure printed on a certificate of analysis, signed by a laboratory that did not manufacture the material, is a measurement. The gap between those two things is the entire subject of this article.

Third-party testing means the analysis was performed by a laboratory with no commercial interest in the result. The manufacturer sends a sample, the laboratory runs the method, and the laboratory reports what it found. That separation matters because the party who benefits from a high number is not the party generating it.

In-house testing is not worthless. A manufacturer running release testing on every lot is doing something meaningful, and for many research applications it is sufficient. But in-house testing and independent testing answer different questions, and a supplier that offers only the former should say so plainly rather than letting the phrase “tested” do ambiguous work.

The two methods that carry most of the weight

Reversed-phase HPLC

Reversed-phase high performance liquid chromatography separates the components of a sample by how strongly each one interacts with a nonpolar stationary phase. The sample is pushed through a packed column under pressure using a gradient of water and an organic solvent, usually acetonitrile, with a small amount of an ion-pairing agent such as trifluoroacetic acid.

Components that interact weakly come off the column early. Components that interact strongly come off later. A detector, typically monitoring ultraviolet absorbance at 214 nm where the peptide bond absorbs, records each component as a peak.

Purity is then reported as area percent:

Chromatographic purity
purity % = (area of the main peak / total area of all peaks) x 100

This is the number most commonly quoted as “98% purity” or similar. It is worth being precise about what it describes. It describes the proportion of ultraviolet-absorbing material that eluted as the main peak. It does not describe the proportion of the vial contents that are peptide, and it does not confirm that the main peak is the peptide you ordered.

Mass spectrometry

That second question is what mass spectrometry answers. The instrument ionizes the sample and measures mass-to-charge ratio, producing an observed molecular mass that can be compared against the theoretical mass calculated from the amino acid sequence.

If the sequence is correct and the material is what it claims to be, observed and theoretical mass agree within the tolerance of the instrument. If they do not, something is wrong: a deletion sequence missing a residue, an incomplete deprotection leaving a side chain group attached, an oxidation, or a different compound entirely.

HPLC without MS tells you the sample is homogeneous. MS without HPLC tells you the expected mass is present somewhere in the mixture. Together they tell you the sample is mostly one thing and that the one thing has the right mass. Neither alone is sufficient, which is why a certificate showing only one of them is showing you half a picture.

Purity is not the same as content

This is the single most misread part of peptide analytics.

Chromatographic purity measures the peptide fraction relative to other ultraviolet-absorbing species. It says nothing about the material in the vial that does not absorb at 214 nm, and a lyophilized peptide contains a good deal of that.

Residual water is present in almost every lyophilizate, typically a few percent, measurable by Karl Fischer titration. Counterions are present because peptides are usually isolated as salts, most often trifluoroacetate from the purification step, and TFA can account for a meaningful share of the mass. Residual solvent and inorganic salts may also be present.

Net peptide content, determined by amino acid analysis or nitrogen determination, is the figure that accounts for all of this:

Net peptide content
net peptide % = (mass of peptide / total mass of lyophilizate) x 100

A lot can honestly report 99% chromatographic purity and 78% net peptide content at the same time. Both figures are correct. They are measuring different denominators. Any experiment where the quantity of peptide matters needs the second figure, and a certificate that omits it leaves that calculation ungrounded.

What else belongs on a genuine third-party report

The lot number, because testing is lot-specific and a certificate that cannot be tied to the specific vial in hand is a marketing document.

The analysis date and the identity of the testing laboratory, including, where the laboratory holds one, its accreditation reference.

The raw chromatogram and mass spectrum, not just the summary figures. A chromatogram shows peak shape, baseline quality and the size of the impurity peaks, and a tabulated number hides all three.

The method parameters: column, gradient, flow rate, detection wavelength. Purity figures are method-dependent, and a gradient chosen to make a sample look clean will do exactly that.

Water content and counterion content, where net peptide content is not separately reported.

Reading the report critically

A few things are worth checking on any certificate before the material goes anywhere near an experiment.

Check that the lot number on the certificate matches the lot number on the vial. This sounds trivial. It is the most common failure.

Check that the observed mass is close to the theoretical mass for the stated sequence, and that the certificate states which one it is reporting, monoisotopic or average.

Look at the chromatogram rather than only the purity figure. A single sharp peak with a flat baseline and one small shoulder is a different material from a main peak with three visible impurities that happen to sum to two percent.

Check the analysis date against the date the material was manufactured. A certificate generated two years before the lot was packaged is describing a different sample.

Be cautious of certificates with no laboratory identified, no method section, no chromatogram, or a purity figure quoted to a suspicious number of decimal places. Analytical measurement has uncertainty, and a report that does not acknowledge any is not reporting carefully.

Why this matters for reproducibility

Research that cannot be reproduced is research that has not established anything. When the input material is uncharacterized, an unexpected result has too many possible explanations to distinguish between: the hypothesis may be wrong, or the material may have been 70% of what the label said, or it may have degraded, or it may have been a deletion sequence with one residue missing.

Lot-specific analytical documentation removes that ambiguity. It does not make the experiment succeed. It makes the experiment interpretable, which is a prerequisite for anything else.

All compounds discussed here are supplied for laboratory research use only. They are not medicines, are not for human or veterinary use, and are not for diagnostic or therapeutic application of any kind.